U.S. Small-Mid Cap Value Equity

The Brandes U.S. Small-Mid Cap Value Equity Strategy seeks long-term capital appreciation by investing primarily in the equity securities of U.S. issuers with equity market capitalizations greater than $1.5 billion but no greater than $7.5 billion at the time of purchase.

Overview

Why U.S. Small-Mid Cap Value Equity?

  • Value: The strategy employs our disciplined, bottom-up investing approach to seek U.S. small-/mid-cap companies trading below our estimates of intrinsic value.
  • Experience: Having managed the U.S. Small-Mid Cap Value Equity Strategy for over 20 years, Brandes is familiar with the intricacies of the vast U.S. small-/mid-cap equity space.
  • Flexibility: The strategy has the ability and willingness to be different than the benchmark.

Performance

As of 30 Sep 2022 | Reporting Currency: EUR

Swipe to View Quarter End
Source: Brandes, Russell. Total return – net and gross of management fees. Periods of greater than one year have been annualized. Past performance is not a guarantee of future results. The strategy primary benchmark is the Russell 2500 Index. It is not possible to invest directly in an index. GIPS® Report available in Resources section below. 

Portfolio

Data displayed as of 30 Sep 2022

Characteristics

Characteristic U.S. Small-Mid Cap Value Equity Russell 2500 Index
Price/Book (x)
Price per share divided by book value per share.
1.2 2.0
Price/Earnings (x)
Price per share divided by earnings per share.
11.3 11.3
Price/Cash Flow (x)
Price per share divided by cash flow per share.
8.8 9.2
Dividend Yield %
Dividends per share divided by price per share.
3.2 1.6
Active Share %
A measure of the percentage of stock holdings in a manager’s portfolio that differs from the benchmark index.
95.4 --
Number of Holdings 75 --
Weighted Average Mkt. Cap (€bil) 5.5 5.2
Portfolio Turnover (TTM) %
(Trailing Twelve Months)
11.5 --
Swipe to View Characteristics

Top 10 Holdings (%)

Company % Country Industry
Amdocs Ltd 4.5 United States IT Services
Change Healthcare Inc 3.4 United States Health Care Technology
NETGEAR Inc 2.9 United States Communications Equipment
Edgewell Personal Care Co 2.8 United States Personal Products
Premier Inc 2.7 United States Health Care Providers & Services
United Therapeutics Corp 2.6 United States Biotechnology
Embraer SA 2.3 Brazil Aerospace & Defense
Taro Pharmaceutical Industries Ltd 2.1 Israel Pharmaceuticals
Citizens Financial Group Inc 2.0 United States Banks
Equity Commonwealth 2.0 United States Equity Real Estate Investment Trusts (REITs)
% of Portfolio 27.3    
Portfolio holdings are subject to change at any time at the discretion of the investment manager.
Swipe to View Top 10 Holdings

Sector Allocation (%)

Swipe to View Sector Allocation (%)

The Brandes U.S. Small-Mid Cap Value Equity Composite seeks to achieve long-term capital appreciation by investing primarily in equity securities of U.S. issuers with equity market capitalizations greater than $1.5 billion, but no greater than $7.5 billion, at the time of purchase. Small and mid-capitalization securities involve greater issuer risk than large capitalization securities, and the markets for such securities may be more volatile and less liquid.

The Russell 2500 with gross dividends measures the performance of the small to mid cap segment of the U.S. equity universe. The benchmark returns are not covered by the report of independent verifiers.

The Russell 2500 Value Index with gross dividends measures the performance of the small to mid cap segment of the U.S. equity universe. Securities are categorized as growth or value based on their relative book to price ratios, historical sales growth, and expected earnings growth.

The portfolio characteristics shown relate to a single account deemed by Brandes to be generally representative of the strategy as of date noted. Not every account will have these exact characteristics. The actual characteristics with respect to any particular account will vary based on a number of factors including but not limited to: (i) the size of t he account; (ii) investment restrictions applicable to the account, if any; and (iii) market exigencies at the time of investment. Data is updated on a quarterly basis.

The results for individual accounts and for different periods may vary. Investors should not rely on prior performance results as a reliable indication of future results. Market conditions may impact performance. The performance results presented were achieved in particular market conditions which may not be repeated. Moreover, the current market volatility and uncertain regulatory environment may have a negative impact on future performance.

Market Capitalization, Price/Book, Price/Earnings, Price/Cash Flow, and Dividend Yield for each security provided by Bloomberg, L.P. Please note that Bloomberg does not provide negative numbers in the data feed. Index fundamentals are calculated from holdings data as provided by the relevant index or by FactSet Fundamentals, excluding negative numbers for consistency. Thus, index fundamentals calculated by Brandes may differ from those computed and published by index providers.

Non-U.S. dollar composite and benchmark returns shown with the following strategies were calculated and converted using the exchange rate fluctuations between the two currencies of the stated U.S. dollar returns: Asia Pacific (ex-Japan) Equity, Corporate Focus Fixed Income, Global Opportunities Value, Global Small Cap Equity, Global Small-Mid Cap Equity, International Equity, International Small Cap Equity, International Small-Mid Cap Equity, U.S. Small Cap Value Equity, U.S. Small-Mid Cap Value Equity. Non-U.S. dollar composite returns shown with the following strategies were calculated and converted using the exchange rate fluctuations between the two currencies of the stated U.S. dollar returns: Emerging Markets Equity, European Equity, Global Equity, Japan Equity, U.S. Value Equity.
The information and materials in this site are not intended to and shall not constitute an offer to buy or sell shares or provide advisory management services in any jurisdiction where such activity is unlawful and must not be treated as such. Access to and use of this web site is provided on the following Terms and Conditions. Brandes Investment Partners (Europe) Limited is regulated by the Central Bank of Ireland, its offices are located at Alexandra House, The Sweepstakes, Ballsbridge, Dublin, D04 C7H2, Ireland and its registration number in Ireland is 510203.
Brandes Investment Partners® is a registered trademark of Brandes Investment Partners, L.P. in the United States and Canada. This website may also contain trademarks of other companies.

LinkedIn, the LinkedIn logo, and the IN logo are registered trademarks or trademarks of LinkedIn Corporation and its affiliates in the United States and/or other countries.